149 related articles for article (PubMed ID: 38669432)
1. Parathyroid hormone related-protein (PTHrP) in tissues with poor prognosis in prostate cancer patients.
Zhao Y; Lu SM; Zhong B; Wang GC; Jia RP; Wang Q; Long JH
Medicine (Baltimore); 2024 Apr; 103(17):e37934. PubMed ID: 38669432
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone related-protein promotes epithelial-to-mesenchymal transition in prostate cancer.
Ongkeko WM; Burton D; Kiang A; Abhold E; Kuo SZ; Rahimy E; Yang M; Hoffman RM; Wang-Rodriguez J; Deftos LJ
PLoS One; 2014; 9(1):e85803. PubMed ID: 24465715
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Twist-1, E-cadherin and EZH2 in Prostate Cancer: An Immunohistochemical Study.
Abdelrahman AE; Arafa SA; Ahmed RA
Turk Patoloji Derg; 2017; 1(1):198-210. PubMed ID: 28832071
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone-related protein as a potential prostate cancer biomarker: Promoting prostate cancer progression through upregulation of c-Met expression.
Zhao Y; Fu ZY; Feng HY; Peng YH; Yin ZX; Cao JY; Pei CS
Biomol Biomed; 2024 Mar; 24(2):374-386. PubMed ID: 37838928
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer.
Katz B; Reis ST; Viana NI; Morais DR; Moura CM; Dip N; Silva IA; Iscaife A; Srougi M; Leite KR
PLoS One; 2014; 9(11):e113700. PubMed ID: 25409297
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of parathyroid hormone-related protein in prostate cancer as compared with benign prostatic hyperplasia.
Asadi F; Farraj M; Sharifi R; Malakouti S; Antar S; Kukreja S
Hum Pathol; 1996 Dec; 27(12):1319-23. PubMed ID: 8958305
[TBL] [Abstract][Full Text] [Related]
7. Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cells.
Park SI; McCauley LK
Endocr Relat Cancer; 2012 Jun; 19(3):243-54. PubMed ID: 22291434
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
9. Co-expression of parathyroid hormone related protein and TGF-beta in breast cancer predicts poor survival outcome.
Xu C; Wang Z; Cui R; He H; Lin X; Sheng Y; Zhang H
BMC Cancer; 2015 Nov; 15():925. PubMed ID: 26597083
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of the EMT-related proteins and their interrelationships in prostate cancer. An immunohistochemical study.
Parol-Kulczyk M; Gzil A; Maciejewska J; Bodnar M; Grzanka D
PLoS One; 2021; 16(6):e0253112. PubMed ID: 34157052
[TBL] [Abstract][Full Text] [Related]
11. Expression of parathyroid hormone-related protein and its receptor in bone metastases from prostate cancer.
Iddon J; Bundred NJ; Hoyland J; Downey SE; Baird P; Salter D; McMahon R; Freemont AJ
J Pathol; 2000 Jun; 191(2):170-4. PubMed ID: 10861577
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 expression in human lung adenocarcinoma.
Monego G; Lauriola L; Ramella S; D'Angelillo RM; Lanza P; Granone P; Ranelletti FO
Chest; 2010 Apr; 137(4):898-908. PubMed ID: 19952062
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the cell-specific expression of parathyroid hormone-related protein in normal and neoplastic prostate tissue.
Wu G; Iwamura M; di Sant'Agnese PA; Deftos LJ; Cockett AT; Gershagen S
Urology; 1998 May; 51(5A Suppl):110-20. PubMed ID: 9610565
[TBL] [Abstract][Full Text] [Related]
14. Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer.
Liu T; Zhang X; Shang M; Zhang Y; Xia B; Niu M; Liu Y; Pang D
J Surg Oncol; 2013 Feb; 107(2):188-94. PubMed ID: 22886823
[TBL] [Abstract][Full Text] [Related]
15. EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells.
Bhatia V; Saini MK; Shen X; Bi LX; Qiu S; Weigel NL; Falzon M
Mol Cancer Ther; 2009 Jul; 8(7):1787-98. PubMed ID: 19584236
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Met receptor pathway in aggressive behavior of colorectal cancer cells induced by parathyroid hormone-related peptide.
Novoa Díaz MB; Carriere P; Gigola G; Zwenger AO; Calvo N; Gentili C
World J Gastroenterol; 2022 Jul; 28(26):3177-3200. PubMed ID: 36051345
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone-related protein as a growth regulator of prostate carcinoma.
Dougherty KM; Blomme EA; Koh AJ; Henderson JE; Pienta KJ; Rosol TJ; McCauley LK
Cancer Res; 1999 Dec; 59(23):6015-22. PubMed ID: 10606251
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma.
Luo W; Fang W; Li S; Yao K
Int J Cancer; 2012 Oct; 131(8):1863-73. PubMed ID: 22307379
[TBL] [Abstract][Full Text] [Related]
19. Correlation between E-cadherin/β-catenin, Vimentin expression, clinicopathologic features and drug resistance prediction in naïve prostate cancer: A molecular and clinical study.
Said R; Hernández-Losa J; Derouiche A; Moline T; de Haro RSL; Zouari S; Blel A; Rammeh S; Ouerhani S
Genesis; 2024 Feb; 62(1):e23543. PubMed ID: 37649322
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone-related peptide: expression in prostate cancer bone metastases.
Bryden AA; Islam S; Freemont AJ; Shanks JH; George NJ; Clarke NW
Prostate Cancer Prostatic Dis; 2002; 5(1):59-62. PubMed ID: 15195132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
